CP
GEHC icon

Camelot Portfolios’s GE HealthCare GEHC Stock Holding History

Camelot Portfolios’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,767
Closed -$227K – 329
2025
Q4 		$227K Sell
2,767
-184
-6% -$14.3K 0.14% 162
2025
Q3 		$222K Sell
2,951
-297
-9% -$22.2K 0.13% 167
2025
Q2 		$241K Sell
3,248
-380
-10% -$26.5K 0.14% 169
2025
Q1 		$293K Buy
+3,628
New +$312K 0.18% 148
2024
Q3 		– Sell
-3,838
Closed -$299K – 308
2024
Q2 		$299K Buy
3,838
+1,353
+54% +$110K 0.17% 136
2024
Q1 		$226K Sell
2,485
-1,856
-43% -$154K 0.22% 110
2023
Q4 		$336K Buy
+4,341
New +$304K 0.2% 129
2023
Q3 		– Sell
-3,653
Closed -$297K – 155
2023
Q2 		$297K Buy
3,653
+685
+23% +$54.7K 0.19% 137
2023
Q1 		$244K Buy
+2,968
New +$212K 0.17% 150

Other funds holding GEHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Camelot Portfolios's GEHC Position: Q1 2026 in Review

Camelot Portfolios sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,767 shares — an estimated $227K sold.

Camelot Portfolios first reported a position in GEHC in Q1 2023 and held it in 9 quarters. The position peaked at $336K in Q4 2023. 1,272 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Camelot Portfolios reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Camelot Portfolios sold 2,767 GE HealthCare shares in Q1 2026, an estimated $227K.
  • Camelot Portfolios first reported a position in GE HealthCare in Q1 2023 and held it in 9 quarters.
  • Camelot Portfolios's GE HealthCare position peaked at $336K in Q4 2023.
  • 1,272 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.